Inspire is scheduled to present at
https://wsw.com/webcast/stifel74/register.aspx?conf=stifel74&page=insp&url=https://wsw.com/webcast/stifel74/insp/2113108
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
Source:
2022 GlobeNewswire, Inc., source